Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, participated in a U.S. Food and Drug Administration meeting about...
People Archives - Page 37 of 37 - Insights
Skip to Content MayoACCESS MayoLINK...
At the recent AACC annual scientific meeting, Melissa Snyder, Ph.D., Consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, presented the short course, “Clinical and Laboratory Aspects of...
Leslie Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, recently authored an article in Clinical...
Jeff Meeusen, Ph.D., a clinical chemist and Co-Director of Cardiovascular Laboratory Medicine at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News that discusses patient fasting in lipid testing. While...
Pathways Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
Autoimmune Neurology Testing - Insights
Autoimmune neurology is a rapidly evolving subspecialty driven by the discovery that the immune system can target virtually any structure within the
Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Advanced Crohn's monitoring test launched by Mayo Clinic - Insights
Mayo Clinic Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic monitoring of Crohn's...
Study can improve understanding of how disability develops in MS - Insights
Mayo Clinic researchers have identified clear differences in brain and spinal cord scarring in patients with demyelinating diseases.